Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

NCT02246764 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Glaucoma

Interventions

DRUG: AR-13324 Ophthalmic Solution 0.02%
DRUG: AR-13324 Ophthalmic Solution 0.02% BID
DRUG: Timolol maleate Ophthalmic Solution 0.5% BID
OTHER: Placebo

Sponsor

Aerie Pharmaceuticals